Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.
Urinary biomarkers for bladder cancer detection are constrained by inadequate sensitivity or specificity. Here we evaluate the diagnostic accuracy of Mcm5, a novel cell cycle biomarker of aberrant growth, alone and in combination with NMP22.1677 consecutive patients under investigation for urinary t...
Main Authors: | John D Kelly, Tim J Dudderidge, Alex Wollenschlaeger, Odu Okoturo, Keith Burling, Fiona Tulloch, Ian Halsall, Teresa Prevost, Andrew Toby Prevost, Joana C Vasconcelos, Wendy Robson, Hing Y Leung, Nikhil Vasdev, Robert S Pickard, Gareth H Williams, Kai Stoeber |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3392249?pdf=render |
Similar Items
-
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
by: Dudderidge, T, et al.
Published: (2005) -
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
by: Shetty, A, et al.
Published: (2005) -
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
by: Kingsbury, SR, et al.
Published: (2005) -
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
by: Dudderidge, T, et al.
Published: (2007) -
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
by: Saachi Chhaya, et al.
Published: (2023-01-01)